Stephane Postic

Stephane Postic's work experience includes being the Chief Financial Officer at MedinCell, a pharmaceutical company that develops long-acting injectable treatments. Stephane also served as a Partner at QUARTAM and held the position of Chief Financial Officer at Egle Therapeutics, a biotechnology company focused on immunotherapies for oncology and autoimmune diseases. Additionally, they worked as the Interim Chief Executive Officer and Chief Financial Officer at Da Volterra, a biopharmaceutical company specializing in infection prevention and treatment. Stephane served as the CFO at H-Immune, a company developing antibody-based therapeutics, and OCR - Oncovet Clinical Research, which conducts comparative medicine studies for cancer drug development. Prior to that, they were the CEO of NATURALPHA, a consulting company for nutrition and health products, and the CFO of GENFIT, a biopharmaceutical company. Stephane began their career as a Financial Controller at REDCATS GROUP.

Stephane Postic attended Bury from 1984 to 1992, where they earned a Bac C. Stephane then attended Ste Croix de Neuilly from 1992 to 1993, where they completed Classe Préparatoire. Finally, from 1993 to 1996, they studied Accounting and Finance at emlyon business school.